Approval · Notice of Compliance 20981 · 2018
SYNOVEX PLUS: Notice of Compliance 20981
Issued June 14, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20981
- Date
- June 14, 2018
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug substance manufacturer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNOVEX PLUS | 02162830 | Marketed |
Medicinal ingredients
- ESTRADIOL BENZOATE 28 MG per IMP
- TRENBOLONE ACETATE 200 MG per IMP